Novartis - Production Stopped
NOVARTIS, the manufacturer of many common OTC pharmaceuticals for human and animal use, has volunteered to stop production at their manufacturing plant in Lincoln, Nebraska. The closure is temporary, but a length of time has yet to be determined.
On the human side, the factory closure means a temporary interruption in the manufacturing and shipping of common brand names like Maalox, Excedrin, Theraflu, and Triaminic, as well as a number of prescription medications. On the veterinary side, the popular heartworm preventative Interceptor, and its sister product Sentinel, will be affected. Park Avenue Animal Hospital has a limited stock of Interceptor available for clients who are in need of it immediately, and other heartworm preventatives are available in the event that our stock runs out.
The suspension of production at the facility is voluntary, and was done to facilitate Novartis's implementation of certain manufacturing process improvements. These improvements are intended to address the possibility of rare instances of errors in the packaging of pharmaceuticals (both prescription and non-) produced at the facility. The temporary supply disruption is not related to the efficacy or safety of the products themselves. If you have any questions about Norartis please contact the clinic.
Being admitted to the profession of veterinary medicine, I solemnly swear to use my scientific knowledge and skills for the benefit of society through the protection of animal health, the relief of animal suffering, the conservation of animal resources, the promotion of public health, and the advancement of medical knowledge.
